ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 0505 • ACR Convergence 2022

    Longitudinal Trajectories of Central Pain Sensitization in People with or at Risk of Knee Osteoarthritis

    Kosaku Aoyagi1, Na Wang2, Laura Frey-Law3, Cora E. Lewis4, Michael Nevitt5 and Tuhina Neogi2, 1Boston University, Quincy, MA, 2Boston University School of Medicine, Boston, MA, 3University of Iowa, Iowa City, IA, 4University of Alabama at Birmingham, Birmingham, AL, 5University of California at San Francisco, Orinda, CA

    Background/Purpose: Central pain sensitization is a major contributor to pain severity in knee osteoarthritis (OA). Central sensitization is induced by neuroplastic changes in the central…
  • Abstract Number: 0972 • ACR Convergence 2022

    Automated Joint Space Width Measurement for Hand Osteoarthritis: A Deep Learning Approach

    Zhiheng Chang1, Juan Shan2, Yue Wang2, Xinyue Sun3, Jeffrey Driban4, Timothy McAlindon5, Jeffrey Duryea6, Lena Schaefer6, Charles Eaton7 and Ming Zhang8, 1Wentworth Institute of Technol, Boston, MA, 2Pace University, New York, NY, 3Shandong University, Qing Dao, Shandong, China, 4Tufts Medical Center, Westborough, MA, 5Tufts Medical Center, Arlington, MA, 6Brigham and Women's Hospital, Boston, MA, 7Brown University, Pawtucket, RI, 8Boston University, Westford, MA

    Background/Purpose: Hand osteoarthritis (OA) can be assessed visually through radiographs using Kellgren and Lawrence (KL) system. However, the KL grading system is not fully objective…
  • Abstract Number: 1643 • ACR Convergence 2022

    Use of Oral Analgesics and Risk of Comorbidities in Osteoarthritis: Findings from Primary Care Settings in the UK

    Subhashisa Swain1, Carol Coupland2, Anne Kamps3, Jos Runhaar4, Andrea Dell ‘Isola5, Aleksandra Turkiewicz5, Danielle E Robinson1, Victoria Y Strauss1, Christian Mallen6, Chang-Fu Kuo7, Aliya Sarmanova8, Daniel Prieto Alhambra1, Martin Englund5, Sita Bierma-Zeinstra3, Michael Doherty2 and Weiya Zhang2, 1University of Oxford, Oxford, United Kingdom, 2University of Nottingham, Nottingham, United Kingdom, 3Erasmus University Medical Centre, Rotterdam, Netherlands, 4Erasmus Medical Center, Rotterdam, Netherlands, 5Lund University, Lund, Sweden, 6Keele University, Keele, United Kingdom, 7Chang Gung Memorial Hospital, Taoyuan, Taiwan, 8University of Bristol, Bristol, United Kingdom

    Background/Purpose: People with osteoarthritis (OA) often have multiple other conditions (comorbidities).Role of different oral analgesics on the development of comorbidities in people with OA have…
  • Abstract Number: 1893 • ACR Convergence 2022

    Antihistamine Use and Structural Progression of Knee OA: A Post-Hoc Analysis of Two Phase 3 Clinical Trials

    Asger Bihlet1, Claire Miller1, Inger Byrjalsen1, Morten Karsdal2, Jeppe Andersen1, Tharaknath Rao3 and Matthew Baker4, 1NBCD, Copenhagen, Denmark, 2Nordic Bioscience, Herlev, Denmark, 3Mobility Bio, San Diego, CA, 4Mobility Bio, San Diego

    Background/Purpose: Prior studies indicate that mast cells are involved in chronic inflammation and that their activity in the synovium may contribute to structural progression of…
  • Abstract Number: 1909 • ACR Convergence 2022

    Corticosteroids with or Without Hyaluronic Acid Injections in the Treatment of Trapeziometacarpal (TMC) Osteoarthritis : The Randomised Multicentre RHIZ’ART Trial Study Protocol

    Grégoire Cormier1, Amelie Denis2, CHARLES LESKE3, Stephane Varin1, Jerome Dimet4, Lucie Planche1 and Benoit Le Goff5, 1CHD Vendee, La Roche Sur Yon, France, 2CH Le Mans, Le Mans, France, 3Hospital, Cholet, France, 4CH Mont de Marsan, Mont de Marsan, France, 5CHU Nantes, Nantes, France

    Background/Purpose: Trapeziometacarpal osteoarthritis is highly prevalent (affects 10 to 25% of people). Treatment modalities consist of non-pharmacological and pharmacological measures, including either corticosteroid or hyaluronic…
  • Abstract Number: 2260 • ACR Convergence 2022

    Transcutaneous Vagal Nerve Stimulation Improves Destabilized Medial Meniscus-Induced Osteoarthritis Pain Associated with Significant Serum Biomarker Changes

    Shivmurat Yadav1, Monika Niewiadomska1, Lynsie Morris2, Taylor Conner2, Jessica Lumry2, Sanique South3, Emmaline Prinz2, Matlock Jeffries2, Timothy Griffin2, Stavros Stavrakis1 and Mary Beth Humphrey1, 1University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma CIty, OK, 3Oklahoma Medical Research Foundation, Okahoma City, OK

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, affecting over 32.5 million US adults and characterized by pain, stiffness, swelling and functional disability.…
  • Abstract Number: 0023 • ACR Convergence 2022

    New Biomarkers in Hand Osteoarthritis: The Micro-RNA Signature

    Maxime Auroux1, Marjorie Millet2, Blandine Merle2, Elisabeth Fontanges1, Florence Duvert1, Evelyne Gineyts3, Jean-Charles Rousseau3, Olivier Borel2, Alexandre Mercier1, Eric LESPESSAILLES4 and Roland Chapurlat1, 1Hospices Civils de Lyon, LYON, France, 2INSERM U1033, LYON, France, 3INSERM 1033, Lyon, France, 4Regional hospital centre of Orleans, France, ORLEANS, Centre, France

    Background/Purpose: Hand osteoarthritis (HOA) is a highly prevalent disease, associated with important disability and socio-economic burden. Erosive HOA, almost exclusively found in women, induces more…
  • Abstract Number: 0552 • ACR Convergence 2022

    Identifying Subgroups of Patients Undergoing Knee Replacement

    Brooke McGinley1, Gabriela Rabasa2, Tuhina Neogi3, David Felson2 and Michael LaValley4, 1Boston University School of Public Health, Boston, MA, 2Boston University, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Boston University School of Public Health, Arlington, MA

    Background/Purpose: Knee replacement surgery (KR) is prevalent in the US with estimated lifetime risk from age 25 of 7% for males and 9.5% for females,…
  • Abstract Number: 1102 • ACR Convergence 2022

    An Online Program for Primary Care Practitioners Enhances Confidence in the Ability to Care for Patients with or at Risk of Painful Knee Osteoarthritis

    Lisa Mandl, Myriam Lin, Nicole Wall, Erin Mich-Gennari, Emilia Klapak, Anan Nathif, Martha O'Brasky-Crawley and Juliet Aizer, Hospital for Special Surgery, New York, NY

    Background/Purpose: Primary care practitioners (PCPs) care for the majority of patients with knee osteoarthritis (KOA). However, lack of training and access to resources makes it…
  • Abstract Number: 1644 • ACR Convergence 2022

    Effect of a Lifestyle Program Based on a Whole Food Plant-based Diet, Physical Activity, and Stress Management in Patients with Metabolic Syndrome-Associated Osteoarthritis: A Randomized Controlled Trial

    Wendy Walrabenstein1, Carlijn Wagenaar1, Marike van der Leeden2, Martijn Gerritsen1, Martin van der Esch1 and Dirkjan van Schaardenburg2, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Amsterdam UMC, Amsterdam, Netherlands

    Background/Purpose: Metabolic syndrome with low grade inflammation is associated with chronic diseases including osteoarthritis (OA) (1). A combination of an intensive diet with exercise produced…
  • Abstract Number: 1894 • ACR Convergence 2022

    A Phase 2, 104-Week Study of Repeat Lorecivivint Injections Evaluating Safety, Efficacy, and Bone Health Utilizing Quantitative Computed Tomography (qCT) in Knee Osteoarthritis (OA-06)

    Yusuf Yazici1, Christopher Swearingen2, Heli Ghandehari3, Jon Britt4, ismail simsek5, Mark Fineman6, Sarah Kennedy2, Jeyanesh Tambiah7 and Nancy Lane8, 1New York University School of Medicine, La Jolla, CA, 2Biosplice Therapeutics, Inc, San Diego, CA, 3Biosplice Therapeutics, Inc., San Diego, CA, 4Biosplice Therapeutics, Inc., Los Angeles, CA, 5Alpine Immunesciences, San Diego, CA, 6Biosplice Therapeutics, San Diego, CA, 7Biosplice Ther Inc., San Diego, CA, 8University of California Davis, Hillsborough, CA

    Background/Purpose: Knee osteoarthritis (OA) is a common joint disorder associated with pain, disability, and joint damage. There is a large unmet need for safe and…
  • Abstract Number: 1910 • ACR Convergence 2022

    Evaluation of Dynamic Effects of Depressive Symptoms on Functional Outcomes in Knee Osteoarthritis

    Rhea Mehta1, Marc Hochberg2, Michelle Shardell1, Alice Ryan1, Yu Dong1, Brock Beamer1, Jason Peer2, Megan Schuler3, Joseph Gallo4, Elizabeth Stuart4 and Alan Rathbun1, 1University of Maryland, School of Medicine, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD, 3Rand Inc., Boston, MA, 4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

    Background/Purpose: Knee OA is a leading cause of functional decline, and psychiatric comorbidity is common, particularly major depression. Depressive symptoms decrease physical activity and exacerbate…
  • Abstract Number: 2261 • ACR Convergence 2022

    Pain in Osteoarthritis – Identification of GPR34 and GPR150 as Novel Targets in the Dorsal Root Ganglia

    Matthew Wood1, Terese Geraghty2, David Thomas3, Alia Obeidat1, Jun Li2, Richard Miller4, Rachel Miller1 and Anne-Marie Malfait5, 1Rush University Medical Center, Chicago, IL, 2Rush University, Chicago, IL, 3University of Minnesota Internal Medicine Residency, St. Paul, MN, 4Northwestern University, Evaston, IL, 5Rush University, Oak Park, IL

    Background/Purpose: Osteoarthritis (OA) is a leading cause of chronic pain worldwide. Currently available pain-alleviating therapies are often inadequate and associated with serious adverse effects, resulting…
  • Abstract Number: 0025 • ACR Convergence 2022

    Wnt Pathway/Innate Immunity Equilibrium in OA Articular Cells

    Eloi Franco-Trepat1, Ana Alonso Pérez1, María Guillán-Fresco2, Miriam López Fagúndez1, Andrés Pazos-Pérez3, Antia Crespo Golmar4, María Piñeiro-Ramil5, Ana Lois Iglesias6, Alberto Jorge-Mora1 and Rodolfo Gomez1, 1MSP Group - Institute IDIS - CHUS - SERGAS, Santiago de Compostela, Spain, 2MSP Group - Institute IDIS - CHUS - SERGAS, Catoira, Spain, 3MSP Group - Institute IDIS - CHUS - SERGAS, Pontevedra, Spain, 4MSP Group - Institute IDIS - CHUS - SERGAS, León, Spain, 5MSP Group - Institute IDIS - CHUAC - SERGA, A Coruña, Spain, 6MSP Group - Institute IDIS - CHUAC - SERGAS, A Coruña, Spain

    Background/Purpose: The progressive degradation of osteoarthritis (OA) cartilage has been associated with articular innate immune responses (IIR) mediated by the Toll-like receptor 4 (TLR4). Additionally,…
  • Abstract Number: 0553 • ACR Convergence 2022

    Stair Climbing Difficulty and Risk of Functional Limitation in Knee Osteoarthritis: A Simple Functional Vital Sign?

    Jason Jakiela1, Dana Voinier1, Yvonne Golightly2, Jennifer Horney1, Thomas Bye1, Jéssica Bianca Aily1 and Daniel White1, 1University of Delaware, Newark, DE, 2University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Knee osteoarthritis (OA) is a leading cause of functional limitation in older adults, and difficulty with climbing stairs is often the first-reported limitation. As…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology